{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:07:11Z","timestamp":1788916031315,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-026-28178-3","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:45:09Z","timestamp":1782373509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary biliary cholangitis mortality in Europe: a temporal and spatial view across the period 2002\u20132022"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0557-974X","authenticated-orcid":false,"given":"Angelica","family":"Ortega-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2686-7545","authenticated-orcid":false,"given":"Germ\u00e1n","family":"S\u00e1nchez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-6685","authenticated-orcid":false,"given":"Ana","family":"Villaverde-Hueso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-3153","authenticated-orcid":false,"given":"Greta","family":"Arias-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8560-1336","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Alonso-Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"28178_CR1","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/ajg.2015.312","volume":"110","author":"U Beuers","year":"2015","unstructured":"Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DEJ, Lindor K, et al. Changing Nomenclature for PBC: From \u2018Cirrhosis\u2019 to \u2018Cholangitis\u2019. Am J Gastroenterol. 2015;110:1536\u20138. https:\/\/doi.org\/10.1038\/ajg.2015.312.","journal-title":"Am J Gastroenterol"},{"key":"28178_CR2","first-page":"358","volume":"99","author":"MA Mart\u00edn Scapa","year":"2007","unstructured":"Mart\u00edn Scapa MA, Cano A. Cirrosis biliar primaria. Rev Esp Enfermedades Dig. 2007;99:358\u2013358.","journal-title":"Rev Esp Enfermedades Dig"},{"key":"28178_CR3","first-page":"9","volume":"31","author":"M Posada","year":"2008","unstructured":"Posada M, Mart\u00edn-Arribas C, Ram\u00edrez A, Villaverde A, Abaitua I. Enfermedades raras: Concepto, epidemiolog\u00eda y situaci\u00f3n actual en Espa\u00f1a. Sist Sanit Navar. 2008;31:9\u201320.","journal-title":"Sist Sanit Navar"},{"key":"28178_CR4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00535-017-1333-2","volume":"52","author":"A Floreani","year":"2017","unstructured":"Floreani A, Tanaka A, Bowlus C, Gershwin ME. Geoepidemiology and changing mortality in primary biliary cholangitis. J Gastroenterol. 2017;52:655\u201362. https:\/\/doi.org\/10.1007\/s00535-017-1333-2.","journal-title":"J Gastroenterol"},{"key":"28178_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1157\/13127093","volume":"31","author":"A Par\u00e9s","year":"2008","unstructured":"Par\u00e9s A. Historia natural de la cirrosis biliar primaria. Gastroenterol Hepatol. 2008;31:500\u20137. https:\/\/doi.org\/10.1157\/13127093.","journal-title":"Gastroenterol Hepatol"},{"key":"28178_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.4067\/s0034-98872022000700889","volume":"150","author":"F Ram\u00edrez","year":"2022","unstructured":"Ram\u00edrez F, Urz\u00faa \u00c1, Roblero JP, Cattaneo M, Hurtado C, Poniachik J, et al. Primary biliary cholangitis. Experience in 179 patients. Rev M\u00e9dica Chile. 2022;150:889\u201395. https:\/\/doi.org\/10.4067\/s0034-98872022000700889.","journal-title":"Rev M\u00e9dica Chile"},{"key":"28178_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.autrev.2014.01.041","volume":"13","author":"CL Bowlus","year":"2014","unstructured":"Bowlus CL, Gershwin ME. The diagnosis of primary biliary cirrhosis. Autoimmun Rev. 2014;13:441\u20134. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.041.","journal-title":"Autoimmun Rev"},{"key":"28178_CR8","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015;386:1565\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(15)00154-3.","journal-title":"Lancet"},{"key":"28178_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","volume":"20","author":"TC Mahl","year":"1994","unstructured":"Mahl TC, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol. 1994;20:707\u201313. https:\/\/doi.org\/10.1016\/S0168-8278(05)80139-4.","journal-title":"J Hepatol"},{"key":"28178_CR10","doi-asserted-by":"publisher","first-page":"e0179","DOI":"10.1097\/HC9.0000000000000179","volume":"7","author":"J Trivella","year":"2023","unstructured":"Trivella J, John BV, Levy C. Primary biliary cholangitis: Epidemiology, prognosis, and treatment. Hepatol Commun. 2023;7:e0179. https:\/\/doi.org\/10.1097\/HC9.0000000000000179.","journal-title":"Hepatol Commun"},{"key":"28178_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2020.0028","volume":"27","author":"A Tanaka","year":"2021","unstructured":"Tanaka A. Current understanding of primary biliary cholangitis. Clin Mol Hepatol. 2021;27:1\u201321. https:\/\/doi.org\/10.3350\/cmh.2020.0028.","journal-title":"Clin Mol Hepatol"},{"key":"28178_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.32074\/1591-951X-245","volume":"113","author":"S Sarcognato","year":"2021","unstructured":"Sarcognato S, Sacchi D, Grillo F, Cazzagon N, Fabris L, Cadamuro M, et al. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis. Pathologica. 2021;113:170\u201384. https:\/\/doi.org\/10.32074\/1591-951X-245.","journal-title":"Pathologica"},{"key":"28178_CR13","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review. J Hepatol. 2012;56:1181\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2011.10.025.","journal-title":"J Hepatol"},{"key":"28178_CR14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/jgh.15329","volume":"36","author":"T Lv","year":"2021","unstructured":"Lv T, Chen S, Li M, Zhang D, Kong Y, Jia J. Regional variation and temporal trend of primary biliary cholangitis epidemiology: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2021;36:1423\u201334. https:\/\/doi.org\/10.1111\/jgh.15329.","journal-title":"J Gastroenterol Hepatol"},{"key":"28178_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1055\/s-0034-1383726","volume":"34","author":"BD Juran","year":"2014","unstructured":"Juran BD, Lazaridis KN. Environmental Factors in Primary Biliary Cirrhosis. Semin Liver Dis. 2014;34:265\u201372. https:\/\/doi.org\/10.1055\/s-0034-1383726.","journal-title":"Semin Liver Dis"},{"key":"28178_CR16","doi-asserted-by":"publisher","unstructured":"Ma D, Ma J, Zhao C, Tai W. Reasons why women are more likely to develop primary biliary cholangitis. Heliyon. 2024;10. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25634.","DOI":"10.1016\/j.heliyon.2024.e25634"},{"key":"28178_CR17","doi-asserted-by":"publisher","first-page":"25906","DOI":"10.1038\/srep25906","volume":"6","author":"A Lleo","year":"2016","unstructured":"Lleo A, Jepsen P, Morenghi E, Carbone M, Moroni L, Battezzati PM, et al. Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis. Sci Rep. 2016;6:25906. https:\/\/doi.org\/10.1038\/srep25906.","journal-title":"Sci Rep"},{"key":"28178_CR18","unstructured":"WHO Mortality Database - WHO. https:\/\/www.who.int\/data\/data-collection-tools\/who-mortality-database. Accessed 4 May 2026."},{"issue":"20000215","key":"28178_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(sici)1097-0258","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(20000215):335\u201351. https:\/\/doi.org\/10.1002\/(sici)1097-0258. )19:3%253C335::aid-sim336%253E3.0.co;2-z.","journal-title":"Stat Med"},{"key":"28178_CR20","unstructured":"APC\/AAPC\/Tau Confidence Intervals. Joinpoint Help System. https:\/\/surveillance.cancer.gov\/help\/joinpoint\/setting-parameters\/method-and-parameters-tab\/apc-aapc-tau-confidence-intervals. Accessed 15 May 2026."},{"key":"28178_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/978-3-319-67144-4_28","volume":"1031","author":"G Arias Merino","year":"2017","unstructured":"Arias Merino G, S\u00e1nchez D\u00edaz G, Villaverde-Hueso A, Posada de la Paz M, Alonso Ferreira V. Mortality Statistics and their Contribution to Improving the Knowledge of Rare Diseases Epidemiology: The Example of Hereditary Ataxia in Europe. Adv Exp Med Biol. 2017;1031:521\u201333. https:\/\/doi.org\/10.1007\/978-3-319-67144-4_28.","journal-title":"Adv Exp Med Biol"},{"key":"28178_CR22","unstructured":"Revision of the European Standard Population -. Report of Eurostat\u2019s task force\u2009\u2013\u20092013 edition. https:\/\/ec.europa.eu\/eurostat\/web\/products-manuals-and-guidelines\/-\/ks-ra-13-028. Accessed 15 May 2026."},{"issue":"19970415","key":"28178_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/(sici)1097-0258","volume":"16","author":"MP Fay","year":"1997","unstructured":"Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med. 1997;16(19970415):791\u2013801. https:\/\/doi.org\/10.1002\/(sici)1097-0258. )16:7%253C791::aid-sim500%253E3.0.co;2-%2523.","journal-title":"Stat Med"},{"key":"28178_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/sim.4780020404","volume":"2","author":"H Inskip","year":"1983","unstructured":"Inskip H, Beral V, Fraser P, Haskey J. Methods for age-adjustment of rates. Stat Med. 1983;2:455\u201366. https:\/\/doi.org\/10.1002\/sim.4780020404.","journal-title":"Stat Med"},{"key":"28178_CR25","unstructured":"Breslow NE, Day NE. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ. 1987;(82):1\u2013406. PMID: 3329634."},{"key":"28178_CR26","doi-asserted-by":"publisher","first-page":"11525","DOI":"10.1038\/s41598-019-47890-2","volume":"9","author":"H-U Marschall","year":"2019","unstructured":"Marschall H-U, Henriksson I, Lindberg S, S\u00f6derdahl F, Thuresson M, Wahlin S, et al. Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort. Sci Rep. 2019;9:11525. https:\/\/doi.org\/10.1038\/s41598-019-47890-2.","journal-title":"Sci Rep"},{"key":"28178_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cgh.2019.08.013","volume":"18","author":"NK Gatselis","year":"2020","unstructured":"Gatselis NK, Goet JC, Zachou K, Lammers WJ, Janssen HLA, Hirschfield G, et al. Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2020;18:684\u2013e6926. https:\/\/doi.org\/10.1016\/j.cgh.2019.08.013.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"28178_CR28","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1053\/gast.2002.36027","volume":"123","author":"M Prince","year":"2002","unstructured":"Prince M, Chetwynd A, Newman W, Metcalf JV, James OFW. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years. Gastroenterology. 2002;123:1044\u201351. https:\/\/doi.org\/10.1053\/gast.2002.36027.","journal-title":"Gastroenterology"},{"key":"28178_CR29","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cgh.2017.12.033","volume":"16","author":"M Lu","year":"2018","unstructured":"Lu M, Zhou Y, Haller IV, Romanelli RJ, VanWormer JJ, Rodriguez CV, et al. Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment. Clin Gastroenterol Hepatol. 2018;16:1342\u2013e13501. https:\/\/doi.org\/10.1016\/j.cgh.2017.12.033.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"28178_CR30","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/hep.510290603","volume":"29","author":"RE Poupon","year":"1999","unstructured":"Poupon RE, Bonnand AM, Chr\u00e9tien Y, Poupon R. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatol Baltim Md. 1999;29:1668\u201371. https:\/\/doi.org\/10.1002\/hep.510290603.","journal-title":"Hepatol Baltim Md"},{"key":"28178_CR31","doi-asserted-by":"publisher","unstructured":"Hahn JW, Yang HR, Moon JS, Chang JY, Lee K, Kim GA, et al. Global incidence and prevalence of autoimmune hepatitis, 1970\u20132022: a systematic review and meta-analysis. eClinicalMedicine. 2023;65. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102280.","DOI":"10.1016\/j.eclinm.2023.102280"},{"key":"28178_CR32","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","volume":"70","author":"PJ Trivedi","year":"2021","unstructured":"Trivedi PJ, Hirschfield GM. Recent advances in clinical practice: epidemiology of autoimmune liver diseases. Gut. 2021;70:1989\u20132003. https:\/\/doi.org\/10.1136\/gutjnl-2020-322362.","journal-title":"Gut"},{"key":"28178_CR33","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.cgh.2020.08.006","volume":"19","author":"A Gerussi","year":"2021","unstructured":"Gerussi A, Bernasconi DP, O\u2019Donnell SE, Lammers WJ, Van Buuren H, Hirschfield G, et al. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2021;19:1688\u2013e169714. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.006.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"28178_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1007\/s00535-009-0090-2","volume":"44","author":"J Kubota","year":"2009","unstructured":"Kubota J, Ikeda F, Terada R, Kobashi H, Fujioka SI, Okamoto R, et al. Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population. J Gastroenterol. 2009;44:1000\u20136. https:\/\/doi.org\/10.1007\/s00535-009-0090-2.","journal-title":"J Gastroenterol"},{"key":"28178_CR35","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1016\/j.cgh.2021.01.029","volume":"19","author":"GJ Webb","year":"2021","unstructured":"Webb GJ, Ryan RP, Marshall TP, Hirschfield GM. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude. Clin Gastroenterol Hepatol Off Clin Pract. J Am Gastroenterol Assoc. 2021;19:2587\u201396. https:\/\/doi.org\/10.1016\/j.cgh.2021.01.029.","journal-title":"J Am Gastroenterol Assoc"},{"key":"28178_CR36","doi-asserted-by":"publisher","unstructured":"Alonso-Ferreira V, Escobar-Mart\u00ednez FJ, Sanchez-Diaz G, De la Posada M. Atlas de Mortalidad debida a Enfermedades Raras en Espa\u00f1a. Instituto de Salud Carlos III (ISCIII). Instituto de Investigaci\u00f3n de Enfermedades Raras (IIER); 2019. https:\/\/doi.org\/10.4321\/repisalud.8847.","DOI":"10.4321\/repisalud.8847"},{"key":"28178_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejim.2017.05.006","volume":"42","author":"NK Gatselis","year":"2017","unstructured":"Gatselis NK, Zachou K, Lygoura V, Azariadis K, Arvaniti P, Spyrou E, et al. Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece. Eur J Intern Med. 2017;42:81\u20138. https:\/\/doi.org\/10.1016\/j.ejim.2017.05.006.","journal-title":"Eur J Intern Med"},{"key":"28178_CR38","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1053\/jhep.2001.29760","volume":"34","author":"MI Prince","year":"2001","unstructured":"Prince MI, Chetwynd A, Diggle P, Jarner M, Metcalf JV, James OF. The geographical distribution of primary biliary cirrhosis in a well-defined cohort. Hepatology. 2001;34:1083\u20138. https:\/\/doi.org\/10.1053\/jhep.2001.29760.","journal-title":"Hepatology"},{"key":"28178_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00535-021-01836-6","volume":"57","author":"K Matsumoto","year":"2022","unstructured":"Matsumoto K, Ohfuji S, Abe M, Komori A, Takahashi A, Fujii H, et al. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study. J Gastroenterol. 2022;57:19\u201329. https:\/\/doi.org\/10.1007\/s00535-021-01836-6.","journal-title":"J Gastroenterol"},{"key":"28178_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bpg.2018.05.011","volume":"34\u201335","author":"R Rosa","year":"2018","unstructured":"Rosa R, Cristoferi L, Tanaka A, Invernizzi P. Geoepidemiology and (epi-)genetics in primary biliary cholangitis. Best Pract Res Clin Gastroenterol. 2018;34\u201335:11\u20135. https:\/\/doi.org\/10.1016\/j.bpg.2018.05.011.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"28178_CR41","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.3748\/wjg.v12.i23.3625","volume":"12","author":"EM Yoshida","year":"2006","unstructured":"Yoshida EM, Riley M, Arbour LT. Autoimmune liver disease and the Canadian First Nations Aboriginal Communities of British Columbia\u2019s Pacific Northwest. World J Gastroenterol WJG. 2006;12:3625\u20137. https:\/\/doi.org\/10.3748\/wjg.v12.i23.3625.","journal-title":"World J Gastroenterol WJG"},{"key":"28178_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2188\/jea.JE20150010","volume":"26","author":"MN Mieno","year":"2016","unstructured":"Mieno MN, Tanaka N, Arai T, Kawahara T, Kuchiba A, Ishikawa S, et al. Accuracy of Death Certificates and Assessment of Factors for Misclassification of Underlying Cause of Death. J Epidemiol. 2016;26:191\u20138. https:\/\/doi.org\/10.2188\/jea.JE20150010.","journal-title":"J Epidemiol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28178-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28178-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28178-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:58:06Z","timestamp":1788915486000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28178-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28178"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28178-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Instituto de Salud Carlos III (CEI PI 36_2023).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2557"}}